Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 136 AL 150

Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts

Al Adem K, Lee S.

Protein Sci. 2023 May;32(5):e4639. doi: 10.1002/pro.4639.

Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer's disease?

Petrovskaya A, Tverskoi A, Medvedeva A, Nazarova M.

Commun Biol. 2023 Apr 14;6(1):416. doi: 10.1038/s42003-023-04717-1.

Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

Lanctôt KL, Chen C, Mah E, Kiss A, Li A, Shade D, Scherer RW, Vieira D, Coulibaly H, Rosenberg PB, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer J, Herrmann N.

Int Psychogeriatr. 2023 Nov;35(11):664-672. doi: 10.1017/S1041610223000327. Epub 2023 Apr 17.

Comprehensive Bibliometric Analysis of Stem Cell Research in Alzheimer's Disease from 2004 to 2022

Wang R, Zhu Y, Qin LF, Xu ZG, Gao XR, Liu CB, Xu GT, Chen YZ.

Dement Geriatr Cogn Disord. 2023;52(2):47-73. doi: 10.1159/000528886. Epub 2023 Apr 17.

Role of Interaction between Zinc and Amyloid Beta in Pathogenesis of Alzheimer's Disease

Kozin SA.

Biochemistry (Mosc). 2023 Jan;88(Suppl 1):S75-S87. doi: 10.1134/S0006297923140055.

An Update on Autophagy as a Target in the Treatment of Alzheimer's Disease

Sose PM, Doshi GM, Kale PP.

Curr Drug Targets. 2023;24(7):547-567. doi: 10.2174/1389450124666230417104325.

Microbiota-gut-brain axis and related therapeutics in Alzheimer's disease: prospects for multitherapy and inflammation control

Li J, Zhang F, Zhao L, Dong C.

Rev Neurosci. 2023 Apr 20;34(6):695-718. doi: 10.1515/revneuro-2023-0006. Print 2023 Aug 28.

Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study

Mateev E, Kondeva-Burdina M, Georgieva M, Zlatkov A.

J Mol Graph Model. 2023 Jul;122:108471. doi: 10.1016/j.jmgm.2023.108471. Epub 2023 Apr 14.

Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

Mummery CJ, Börjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S, Jonsson M, Schneider A, Rinne JO, Ludolph AC, Bodenschatz R, Kordasiewicz H, Swayze EE, Fitzsimmons B, Mignon L, Moore KM, Yun C, Baumann T, Li D, Norris DA, Crean R, Graham DL, Huang E, Ratti E, Bennett CF, Junge C, Lane RM.

Nat Med. 2023 Jun;29(6):1437-1447. doi: 10.1038/s41591-023-02326-3. Epub 2023 Apr 24.

Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer's Disease

Afsar A, Chacon Castro MDC, Soladogun AS, Zhang L.

Int J Mol Sci. 2023 Apr 14;24(8):7258. doi: 10.3390/ijms24087258.

Improving the Treatment Effect of Carotenoids on Alzheimer's Disease through Various Nano-Delivery Systems

Su W, Xu W, Liu E, Su W, Polyakov NE.

Int J Mol Sci. 2023 Apr 21;24(8):7652. doi: 10.3390/ijms24087652.

Current study on diagnosis and treatment of Alzheimer's disease by targeting amyloid b-protein

Hua KY, Zhao WJ.

Folia Neuropathol. 2023;61(1):8-15. doi: 10.5114/fn.2022.119778.

Focusing on oligomeric tau as a therapeutic target in Alzheimer's disease and other tauopathies

Rayman JB.

Expert Opin Ther Targets. 2023 Apr-May;27(4-5):269-279. doi: 10.1080/14728222.2023.2206561. Epub 2023 May 4.

Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer's dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy

Tseng PT, Zeng BS, Suen MW, Wu YC, Correll CU, Zeng BY, Kuo JS, Chen YW, Chen TY, Tu YK, Lin PY, Carvalho AF, Stubbs B, Li DJ, Liang CS, Hsu CW, Sun CK, Cheng YS, Yeh PY, Wu MK, Shiue YL, Su KP.

Brain Behav Immun. 2023 Jul;111:352-364. doi: 10.1016/j.bbi.2023.04.017. Epub 2023 May 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias